ZHIXIN GP HLDG (02187) announced that the group expects to record a net loss of approximately RMB 58 million for the fiscal year ending December 31, 2025. This compares to a net loss of about RMB 75.2 million for the year ended December 31, 2024. The reduction in loss is primarily attributed to the reversal of a net impairment loss, following the recovery of trade receivables for which impairment provisions were made last year. This reversal partly offset the effects of decreased total revenue and an increase in gross loss.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments